Prev：Inhibition of lanosterol synthase linking with MAPK/JNK signaling pathway suppresses endometrial cancer.(KTA2031-7.000)
Next：Targeting JAML promotes normalization of tumour blood vessels to antagonize tumour progression via FAK/SRC and VEGF/VEGFR2 signalling pathways.(KTA2031-5.100)
